학술논문

Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment
Document Type
Article
Source
In: Pediatric Infectious Disease Journal. (Pediatric Infectious Disease Journal, 1 October 2022, 41(10):827-834)
Subject
Language
English
ISSN
15320987
08913668